Tithonia diversifolia and its main active component tagitinin C induce survivin inhibition and G2/M arrest in human malignant glioblastoma cells

Fitoterapia

Volumn 82, Issue 3, 2011, Pages 331-341

  Liao, May Hua ^a,b   Lin, Wen Chieh ^b   Wen, Hsiao Chuan ^b   Pu, Hsiao Fung ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b YUANPEI UNIVERSITY   (Taiwan)

Author keywords

Autophagic cell death; G2 M arrest; Survivin; Tagitinin C; Tithonia diversifolia

Indexed keywords

PLANT EXTRACT; SURVIVIN; TAGITININ C; TITHONIA DIVERSIFOLIA EXTRACT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOPHAGY; CANCER THERAPY; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG ACTIVITY; DRUG PURIFICATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TITHONIA DIVERSIFOLIA; TITHONIAN;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ASTERACEAE; AUTOPHAGY; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; DOWN-REGULATION; GLIOBLASTOMA; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; PHYTOTHERAPY; PLANT EXTRACTS; SESQUITERPENES;

TITHONIA DIVERSIFOLIA;

EID: 79951670029     PISSN: 0367326X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fitote.2010.11.002     Document Type: Article

References (45)

1. D.N. Louis, H. Ohgaki, O.D. Wiestler, W.K. Cavenee, P.C. Burger, A. Jouvet, B.W. Scheithauer, and P. Kleihues Acta Neuropathol 114 2007 97
2. F. Lefranc, N. Sadeghi, I. Camby, T. Metens, O. Dewitte, and R. Kiss Expert Rev Anticancer Ther 6 2006 719
3. D.S. Ziegler, R.D. Wright, S. Kesari, M.E. Lemieux, M.A. Tran, M. Jain, L. Zawel, and A.L. Kung J Clin Invest 118 2008 3109
4. M. Guha, and D.C. Altieri Cell Cycle 8 2009 2708
5. P. Chen, J. Li, L.P. Ge, C.H. Dai, and X.Q. Li Respirology 15 2010 501
6. Lei Y., Geng Z., Guo-Jun W., He W., and Jian-Lin Y. Mol Cell Biochem Jun 19 2010 Epub ahead of print
7. D.C. Altieri Oncogene 22 2003 8581
8. X.C. Peng, L. Yang, L.P. Yang, Y.Q. Mao, H.S. Yang, J.Y. Liu, D.M. Zhang, L.J. Chen, and Y.Q. Wei J Exp & Clinical Cancer Res 27 2008 46
9. W. Yang, T. Sun, J. Cao, and F. Liu Int J Radiat Biol 86 2010 445
10. H. Roca, Z. Varsos, and K.J. Pienta J Biol Chem 283 2008 25057
11. D.C. Altieri Curr Opin Cell Biol 18 2006 609
12. L. Skagias, E. Politi, A. Karameris, D. Sambaziotis, A. Archondakis, A. Ntinis, I. Moreas, O. Vasou, H. Koutselini, and E. Patsouris Anticancer Res 29 2009 4163
13. P.C. Kuo, H.F. Liu, and J.I. Chao J Biol Chem 279 2004 55875
14. Goffin E., Ziemons E., De Mol P., Madureira Mdo C., Martins A.P., da Cunha A.P., Philippe G., Tits M., Angenot L., and Frederich M. Planta Med 68 2002 543
15. J.Q. Gu, J.J. Gills, E.J. Park, E. Mata-Greenwood, M.E. Hawthorne, F. Axelrod, P.I. Chavez, H.H. Fong, R.G. Mehta, J.M. Pezzuto, and A.D. Kinghorn J Nat Prod 65 2002 532
16. E. Goffin, A.P. da Cunha, E. Ziemons, M. Tits, L. Angenot, and M. Frederich Phytochem Anal 14 2003 378
17. Park W.H., Seol J.G., Kim E.S., Hyun J.M., Jung C.W., Lee C.C., Kim B.K., and Lee Y.Y. Cancer Res 60 2000 3065
18. P.N. Span, V.C. Tjan-Heijnen, J.J. Heuvel, J.B. de Kok, J.A. Foekens, and F.C. Sweep Clin Chem 52 2006 1693
19. N. Mizushima, Y. Ohsumi, and T. Yoshimori Cell Struct Funct 27 2002 421
20. T. Yoshimori Biochem Biophys Res Commun 313 2004 453
21. E.Y. Chan Sci Signal 2 2009 51
22. N. Zhu, Y. Shao, L. Xu, L. Yu, and L. Sun Mol Biol Rep 36 2009 2075
23. G.I. Shapiro, and J.W. Harper J Clin Invest 1040 1999 1645
24. J.N. Sarkaria, G.J. Kitange, C.D. James, R. Plummer, H. Calvert, M. Weller, and W. Wick Clin Cancer Res 14 2008 2900
25. D.S. Ziegler, R.D. Wright, S. Kesari, M.E. Lemieux, M.A. Tran, M. Jain, L. Zawel, and A.L. Kung J Clin Invest 118 2008 3109
26. L. Yu, M.J. Lenardo, and E.H. Baehrecke Cell Cycle 3 2004 1124
27. Y. Tsujimoto, and S. Shimizu Cell Death Differ 12 2005 1528
28. T. Kanzawa, Y. Kondo, H. Ito, S. Kondo, and I. Germano Cancer Res 63 2003 2103
29. M. Degtyarev, A. De Maziere, C. Orr, J. Lin, B.B. Lee, J.Y. Tien, W.W. Prior, S. van Dijk, H. Wu, and D.C. Gray J Cell Biol 183 2008 101
30. Y. Geng, L. Kohli, B.J. Klocke, and K.A. Roth Neuro Oncol 12 2010 473
31. W.M. Pardridge Jpn J Pharmacol 87 2001 97
32. S. Zhang, Y.K. Won, C.N. Ong, and H.M. Shen Curr Med Chem Anticancer Agents 5 2005 239
33. N. Motoyama, and K. Naka Curr Opin Genet Dev 14 2004 11
34. M.B. Kastan, and J. Bartek Nature 432 2004 316
35. M. Vairapandi, A.G. Balliet, B. Hoffman, and D.A. Liebermann J Cell Physiol 192 2002 327
36. D.C. Altieri Nat Rev Cancer 8 2008 61
37. L. Zhonghong, L. Lianjie, Z. Changqing, H. Ying, J. Yu, and L. Yan J Exp Clin Cancer Res 27 2008 20
38. G. Ambrosini, C. Adida, and D.C. Altieri Nat Med 3 1997 917
39. F. Li, G. Ambrosini, E.Y. Chu, J. Plescia, S. Tognin, P.C. Marchisio, and D.C. Altieri Nature 396 1998 580
40. P.C. Kuo, H.F. Liu, and J.I. Chao J Biol Chem 279 2004 55875
41. D.S. O'Connor, D. Grossman, J. Plescia, F. Li, H. Zhang, A. Villa, S. Tognin, P.C. Marchisio, and D.C. Altieri Proc Natl Acad Sci USA 97 2000 13103
42. A. Tyagi, R.P. Singh, C. Agarwal, S. Siriwardana, R.A. Sclafani, and R. Agarwal Carcinogenesis 26 2005 1978
43. Y. Wang, P. Ji, J. Liu, R.R. Broaddus, F. Xue, and W. Zhang Mol Cancer 8 2009 8
44. Q. Zhan, M.J. Antinore, X.W. Wang, F. Carrier, M.L. Smith, C.C. Harris, and A.J. Fornace Jr. Oncogene 18 1999 2892
45. F. Végran, R. Boidot, C. Oudin, C. Defrain, M. Rebucci, and S. Lizard-Nacol Oncogene 26 2007 290